INEBILIZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 04:50:03 GMT 2023` Edited by `admin` on `Sat Dec 16 04:50:03 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	74T7185BMM
Record Status	`Validated (UNII)`
Record Version

Download

Related Record	Type

Name

Type

Language

INEBILIZUMAB

Official Name

English

IMMUNOGLOBULIN G2, ANTI-(HUMAN CD19 (ANTIGEN)) (SYNTHETIC HUMAN MONOCLONAL MEDI-551 HEAVY CHAIN), DISULFIDE WITH SYNTHETIC HUMAN MONOCLONAL MEDI-551 .KAPPA.-CHAIN, DIMER

Common Name

English

INEBILIZUMAB [JAN]

Common Name

English

INEBILIZUMAB [MI]

Common Name

English

INEBILIZUMAB [USAN]

Common Name

English

inebilizumab [INN]

Common Name

English

MEDI551

Code

English

Inebilizumab [WHO-DD]

Common Name

English

MEDI-551

Code

English

Classification Tree Code System Code

EU-Orphan Drug

EU/3/17/1856

Created by admin on Sat Dec 16 04:50:03 GMT 2023 , Edited by admin on Sat Dec 16 04:50:03 GMT 2023

FDA ORPHAN DRUG

490415

Created by admin on Sat Dec 16 04:50:03 GMT 2023 , Edited by admin on Sat Dec 16 04:50:03 GMT 2023

FDA ORPHAN DRUG

295209

Created by admin on Sat Dec 16 04:50:03 GMT 2023 , Edited by admin on Sat Dec 16 04:50:03 GMT 2023

FDA ORPHAN DRUG

299209

Created by admin on Sat Dec 16 04:50:03 GMT 2023 , Edited by admin on Sat Dec 16 04:50:03 GMT 2023

Code System Code Type Description

CAS

1299440-37-1

Created by admin on Sat Dec 16 04:50:03 GMT 2023 , Edited by admin on Sat Dec 16 04:50:03 GMT 2023

PRIMARY

INN

9985

Created by admin on Sat Dec 16 04:50:03 GMT 2023 , Edited by admin on Sat Dec 16 04:50:03 GMT 2023

PRIMARY

DRUG BANK

DB12530

Created by admin on Sat Dec 16 04:50:03 GMT 2023 , Edited by admin on Sat Dec 16 04:50:03 GMT 2023

PRIMARY

DAILYMED

74T7185BMM

Created by admin on Sat Dec 16 04:50:03 GMT 2023 , Edited by admin on Sat Dec 16 04:50:03 GMT 2023

PRIMARY

NCI_THESAURUS

C88283

Created by admin on Sat Dec 16 04:50:03 GMT 2023 , Edited by admin on Sat Dec 16 04:50:03 GMT 2023

PRIMARY

FDA UNII

74T7185BMM

Created by admin on Sat Dec 16 04:50:03 GMT 2023 , Edited by admin on Sat Dec 16 04:50:03 GMT 2023

PRIMARY

ChEMBL

CHEMBL2109334

Created by admin on Sat Dec 16 04:50:03 GMT 2023 , Edited by admin on Sat Dec 16 04:50:03 GMT 2023

PRIMARY

USAN

AB-114

Created by admin on Sat Dec 16 04:50:03 GMT 2023 , Edited by admin on Sat Dec 16 04:50:03 GMT 2023

PRIMARY

MERCK INDEX

m12210

Created by admin on Sat Dec 16 04:50:03 GMT 2023 , Edited by admin on Sat Dec 16 04:50:03 GMT 2023

PRIMARY

WIKIPEDIA

INEBILIZUMAB

Created by admin on Sat Dec 16 04:50:03 GMT 2023 , Edited by admin on Sat Dec 16 04:50:03 GMT 2023

PRIMARY

RXCUI

2373951

Created by admin on Sat Dec 16 04:50:03 GMT 2023 , Edited by admin on Sat Dec 16 04:50:03 GMT 2023

PRIMARY

From	To
1_22	1_96
1_148	1_204
1_224	3_218
1_230	2_230
1_233	2_233
1_265	1_325
1_371	1_429
2_22	2_96
2_148	2_204
2_224	4_218
2_265	2_325
2_371	2_429
3_23	3_92
3_138	3_198
4_23	4_92
4_138	4_198

Glycosylation Type

MAMMALIAN, AFUCOSYLATED

Glycosylation Link Type	Site
N	1_301
N	2_301

Related Record Type Details

INEBILIZUMAB-CDON

SUB_CONCEPT->SUBSTANCE

Amount:


					IYZ9TI08W3

B-LYMPHOCYTE ANTIGEN CD19

TARGET->LIGAND

Comments:

B Cell-Depleting Anti-CD19 Antibody

Related Record Type Details


					74T7185BMM

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NON-GLYCOSYLATED(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL